Restart Life Sciences Corp. Stock OTC Markets
Stocks
NMLSF
CA76134J2065
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
OTC Markets
13:49:04 2026-08-19 EDT
|
5-day change | 1st Jan Change | ||
| 0.0628 USD | -6.78% |
|
-6.76% | -27.38% |
| Market Cap | 4.36M 3.16M 2.7M 2.53M 2.31M 302M 4.41M 29.94M 11.64M 152M 11.85M 11.59M 502M | P/E 2024 |
6x | P/E 2025 | -3.05x |
|---|---|---|---|---|---|
| Enterprise Value | 2.96M 2.14M 1.83M 1.71M 1.57M 205M 2.99M 20.29M 7.89M 103M 8.03M 7.86M 340M | EV / Sales 2024 |
-
| EV / Sales 2025 | - |
| Free-Float |
93.45% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -6.78% | ||
| 1 week | -6.76% | ||
| Current month | -0.95% | ||
| 1 month | +12.95% | ||
| 3 months | +26.10% | ||
| 6 months | -35.26% | ||
| Current year | -27.38% |
| 1 week | 0.06 |  | 0.06 |
| 1 month | 0.01 | | 0.09 |
| Current year | 0.01 | | 0.12 |
| 1 year | 0.01 | | 0.12 |
| 3 years | 0.01 | | 0.28 |
| 5 years | 0.01 | | 1.26 |
| 10 years | 0.01 | | 32.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
Steve Loutskou
CEO | Chief Executive Officer | - | 2024-10-21 |
Inez Ho
DFI | Director of Finance/CFO | 42 | 2026-06-02 |
Kelly Pladson
ADM | Chief Administrative Officer | 44 | 2017-01-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Georg Hochwimmer
BRD | Director/Board Member | 58 | 2024-01-02 |
Steve Loutskou
CHM | Chairman | - | 2024-10-21 |
| Director/Board Member | - | 2024-12-09 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -6.78% | -6.76% | - | - | 3.17M | |
| -0.74% | +3.78% | +3.74% | +23.10% | 51.61B | |
| +1.01% | -0.20% | +471.68% | +564.93% | 44.89B | |
| +0.16% | +7.88% | +36.14% | +20.76% | 42.77B | |
| -0.66% | +2.61% | +18.59% | +87.04% | 42.58B | |
| +0.88% | -3.48% | +17.20% | +53.83% | 31.82B | |
| -0.12% | +3.84% | +33.73% | +145.25% | 17.33B | |
| -0.53% | +1.84% | - | - | 16.63B | |
| +0.58% | +4.66% | +7.17% | +30.87% | 14.76B | |
| +1.15% | +4.17% | +84.49% | +50.33% | 14.09B | |
| Average | -0.51% | +4.18% | +84.09% | +122.01% | 30.72B | |
| Weighted average by Cap. | +0.10% | +4.10% | +100.58% | +140.63% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | - |
| Net income | 225K 162K 139K 130K 119K 15.56M 227K 1.54M 599K 7.81M 610K 597K 25.85M | -1.39M -1.01M -862K -806K -737K -96.26M -1.41M -9.54M -3.71M -48.34M -3.77M -3.69M -160M |
| Net Debt | -86.02K -62.19K -53.3K -49.86K -45.58K -5.95M -86.94K -590K -229K -2.99M -234K -228K -9.89M | -1.41M -1.02M -872K -816K -746K -97.42M -1.42M -9.65M -3.75M -48.92M -3.82M -3.74M -162M |
Employees
-
| Date | Price | Change | Volume |
|---|
- Stock Market
- Stocks
- HEAL Stock
- NMLSF Stock
Select your edition
All financial news and data tailored to specific country editions
